Yesterday, I officially graduated from City of Hope Hematology/Oncology fellowship program! I truly can’t believe how fast the 3 years flew by. So grateful for the wonderful experience I had during fellowship and the opportunity to work alongside such inspiring mentors. Excited

Congratulations to this year's #WorldGU25 poster winners! We are excited to spotlight our 19 winners at the Poster Session & Welcome Reception at the 2-day CE-accredited conference in Nashville, TN, Aug 21-23. Join us and receive up to 11.75 CE credits. hubs.la/Q03wLfxZ0

Hats off to Regina Barragan-Carrillo who (w Zeynep Zengin Yale Internal Medicine) put together a beautiful overview of #microbiome modulation for the treatment of #solidtumors in Journal of Clinical Oncology. Citing work from innovative #scientists & #trialists in the field like #Routy, #ElKrief, lisaderosa, #Zitvogel,

Gut bacteria like Akkermansia, Bifidobacterium, and Ruminococcaceae are linked to better outcomes with immune checkpoint inhibitors (ICIs) in melanoma, RCC, and NSCLC. But disrupt the microbiome with antibiotics? ➡️ Higher resistance ➡️ Shorter survival

🚀 4pm at #KCRS25: Rapid Oral Session w Sumanta K. Pal, MD, FASCO Featuring: ▪️ Tom Powles Q-TWiST ▪️ koral shah, md FKSI-23 ▪️ Chad Tang, MD MRWS ▪️ Carolina Alves Costa Silva, MD, PhD Microbiome ▪️ Ruchi Agarwal Global disparities ▪️ #JJones WIRE ▪️ Miguel Zugman Papillary RCC Don’t blink. This one’s fast-paced & packed!

#KCRS25 Rapid Abstract: koral shah, md City of Hope will share new insights into what patients with RCC value most at different stages of disease, and how those priorities shaped the FKSI-23 QoL tool. Read all the abstracts: bit.ly/AbstractsKCRS25 Register: bit.ly/RegisterKCRS25

Excellent insights as always from Sumanta K. Pal, MD, FASCO on industry support for rare subtype trials. We need more champions like him to push boundaries in #KidneyCancer research. KidneyCAN IKCC Kidney Cancer Bryan Lewis Toni Choueiri, MD Hans Hammers OncoAlert Nazli Dizman Emre Yekedüz Laurence Albiges

⭐️ We acknowledge that positive phase II trials don’t always translate into positive phase III results ⭐️Enrollment is challenging in non-clear cell but can be done! ⭐️Industry support can make phase III trials possible and even help accelerate enrollment

What a wonderful keynote at #KCRS25 from Kimryn Rathmell on how to foster growth in #earlycareerinvestigators, with pearls for “young people”, mentors, and institutions alike.

Exciting talk by David Braun at #KCRS2025 on not only the feasibility of personalized neoantigen vaccines in #kidneycancer , but also preclinical evidence of T cell response & preliminary promising clinical activity 💉🧬 KidneyCAN UroToday.com OncoAlert

Ivonescimab in ccRCC Presented by Nazli Dizman at #KCRS25. Targeting tumor microenvironment with cooperative inhibition. Promising concept, eager for results! KidneyCAN IKCC Kidney Cancer Bryan Lewis Toni Choueiri, MD Hans Hammers OncoAlert Sumanta K. Pal, MD, FASCO Emre Yekedüz Laurence Albiges Michael Serzan, MD

🌟Happening now at #KCRS25!! Great talk by koral shah, md on exploring health-related quality of life across the RCC spectrum through a conceptual domain analysis #kidneycancer👇 KidneyCAN OncoAlert UroToday.com

koral shah, md did a stellar presentation on our FKSI-23 measure, developed under the mentorship of Tom Powles and an outstanding expert panel Sumanta K. Pal, MD, FASCO Toni Choueiri, MD Laurence Albiges Viraj Master Brian Rini, MD Sarah P. Psutka MD MS Elizabeth Plimack MD Viktor Grünwald #KCRS25

🌟 Terrific presentation by Ruchi Agarwal at #KCRS25! Highlighted global disparities in clinical trial availability for RCC #kidneycancer👇 OncoAlert KidneyCAN UroToday.com

#KCRS25 Session 4 featured rapid-fire insights from researchers around the globe, highlighting early data and fresh perspectives that may shape the next wave of kidney cancer research. Quality of Life in Belzutifan vs. Everolimus with Tom Powles Patient Experience Across the

Many thanks to Naomi Haas Penn Medicine - Abramson Cancer Center for discussing Wesley Yip City of Hope's adjuvant trial of pembro + #CBM588 - the subject of his ASCO CDA! Terrific session at #KCRS25.

What an incredible slide from Wenxin (Vincent) Xu at #KCRS2025 depicting some of the individuals that have contributed to biomarker research in RCC 🔬. “Biomarkers are a lot of work, but they will reduce both overtreatment and undertreatment” KidneyCAN OncoAlert

Celebrating the winners of the KCRS25 Merit Awards for Clinical Research! 👏 Dr. Yu-wei Chen, University of California San Diego 👏 Dr. Koral Shah, City of Hope 👏 Ruchi Agarwal, University of Pennsylvania #KCRS25 #AcceleratingCures

That's a wrap on #KCRS25! Thank you to everyone who joined us, whether you were with us in Boston or tuning in virtually from around the world. Your presence, questions, and passion for collaboration made this year’s summit one to remember. Until next time, keep pushing the

Amazing! Congrats Yu-Wei Chen, MD, MS koral shah, md and to my “niece” Ruchi, whom I know since 2013 when she was a little girl, but I knew she is brilliant! Way to go to help us conquer cancer! Neeraj Agarwal, MD, FASCO Sumanta K. Pal, MD, FASCO KidneyCAN Tian Zhang, MD, MHS, FASCO (@tiansterzhangmd.bsky) Toni Choueiri, MD Rana McKay, MD, FASCO Pavlos Msaouel